I'm rushed for time at the moment but as Twaynes last title - all of Peptidream's partnerships are based on Macrocyclic/b> peptide candidates. On s side note Novartis already have an equity stake in Peptidream.
- Forums
- ASX - By Stock
- pyc comparison to peptidream
PYC
pyc therapeutics limited
Add to My Watchlist
2.34%
!
$1.31

I'm rushed for time at the moment but as Twaynes last title -...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.31 |
Change
0.030(2.34%) |
Mkt cap ! $758.2M |
Open | High | Low | Value | Volume |
$1.30 | $1.34 | $1.30 | $118.2K | 90.53K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 5301 | $1.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.31 | 3140 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 5301 | 1.300 |
2 | 3190 | 1.295 |
2 | 9425 | 1.285 |
1 | 740 | 1.280 |
3 | 5463 | 1.275 |
Price($) | Vol. | No. |
---|---|---|
1.310 | 3140 | 2 |
1.315 | 9000 | 1 |
1.320 | 685 | 1 |
1.330 | 19588 | 2 |
1.335 | 1300 | 1 |
Last trade - 11.06am 07/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online